Christopher S Henney's Net Worth
$6.24 Million
Who is Christopher S Henney?
Christopher S Henney has an estimated net worth of $6.24 Million. This is based on reported shares across multiple companies, which include Oncothyreon Inc., SGX PHARMACEUTICALS, INC., Prothena Corp plc, AVI BIOPHARMA INC, MYMETICS CORP, XCYTE THERAPIES INC, DENDREON CORP, Anthera Pharmaceuticals Inc, and TECHNE CORP /MN/.
SEC CIK
Christopher S Henney's CIK is 0001242880
Past Insider Trading and Trends
2021 was Christopher S Henney's most active year for acquiring shares with 17 total transactions. Christopher S Henney's most active month to acquire stocks was the month of May. 2021 was Christopher S Henney's most active year for disposing of shares, totalling 34 transactions. Christopher S Henney's most active month to dispose stocks was the month of June. 2005 saw Christopher S Henney paying a total of $315,000.00 for 210,000 shares, this is the most they've acquired in one year. In 2021 Christopher S Henney cashed out on 124,000 shares for a total of $3,841,095.05, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Oncothyreon Inc. No price found
Interim CEO and President
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -60.19K |
—
|
—
|
0
|
Mar 9
| |||
Form 4
| +3.05% | 1.78K |
$3.94 | -$2,340.36 | 60.19K |
Sep 24
| |||
Form 4
| +13.16% | 6.79K |
$3.78 | -$8,561.70 | 58.4K |
Jun 24
| |||
Form 4
| +3.22% | 1.61K |
$3.34 | -$1,793.58 | 51.61K |
Jun 9 - Jun 12
| |||
Form 4
| +102.63% | 25.32K |
$4.11 | $103,972.75 | 50K |
Jan 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 24
| |||
Form 4
| +9.72% | 12.03K |
$3.88 | -$15,562.68 | 135.81K |
Jun 12 - Jun 13
| |||
Form 4
| -1.62% | -2.04K |
$3.06 | -$6,254.64 | 123.78K |
Jun 6 - Jun 7
| |||
Form 4
| +13.04% | 14.51K |
$3.65 | -$17,658.70 | 125.82K |
Mar 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 13
| |||
Form 4
| -1.01% | -1.14K |
$1.86 | -$2,111.10 | 111.31K |
Jun 9
| |||
Form 4
| +7.84% | 8.17K |
$3.67 | $29,998.58 | 112.44K |
Jun 7
| |||
Form 4
| -1.90% | -2.02K |
$3.51 | -$7,093.71 | 104.27K |
Jun 3
| |||
Form 4
| +0.70% | 742 |
$4.15 | -$1,025.05 | 106.29K |
May 3
| |||
Form 4
| +1.73% | 1.79K |
$7.58 | -$4,525.26 | 105.55K |
Dec 31
| |||
Form 4
| -1.47% | -1.55K |
$6.86 | -$10,605.56 | 103.75K |
Dec 4
| |||
Form 4
| +21.66% | 18.75K |
$6.92 | -$43,250.00 | 105.3K |
Dec 1
| |||
Form 4
| -12.62% | -12.50K |
$6.36 | -$79,500.00 | 86.55K |
Nov 18
| |||
Form 4
| +101.93% | 50K |
—
|
—
| 99.05K |
Oct 10
| |||
Form 4
| +15.59% | 6.61K |
—
|
—
| 49.05K |
Jun 9 - Jun 12
| |||
Form 4
| +8.06% | 3.17K |
—
|
—
| 42.44K |
Dec 14
| |||
Form 4
| +25.93% | 8.09K |
—
|
—
| 39.27K |
Jun 3
| |||
Form 4
| +24.74% | 6.18K |
—
|
—
| 31.18K |
Dec 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 12
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Mar 11
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Mar 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 11
| |||
Form 4
|
∞
| 25K |
—
|
—
| 25K |
Dec 10
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
SGX PHARMACEUTICALS, INC. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -97.17K |
$3.00 | -$291,495.00 |
0
|
Aug 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 17
| |||
Form 4
| +25.23% | 19.58K |
—
|
—
| 97.17K |
Feb 6
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Prothena Corp plc (PRTA) Snapshot price: $20.33
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
$33.40 | -$490,166.46 |
0
|
Scheduled
|
Jul 14
| ||
Form 4/A
|
—
|
0
|
$32.65 | -$1,092,181.51 |
0
|
Scheduled
|
Jul 12
| ||
Form 4
|
—
|
0
|
$32.65 | -$1,092,181.51 |
0
|
Jul 12
| |||
Form 4
|
—
|
0
|
$32.08 | -$375,659.22 |
0
|
Jun 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 16
| |||
Form 4
|
—
|
0
|
$38.33 | -$57,015.00 |
0
|
Scheduled
|
Sep 28
| ||
Form 4
|
—
|
0
|
$36.39 | -$297,420.50 |
0
|
Scheduled
|
Jul 17
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 18
| |||
Form 4
|
—
|
0
|
$31.90 | -$302,523.55 |
0
|
Scheduled
|
Feb 27
| ||
Form 4
|
—
|
0
|
$31.86 | -$202,207.35 |
0
|
Scheduled
|
Feb 17
| ||
Form 4/A
|
—
|
0
|
$34.79 | -$562,798.43 |
0
|
Aug 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 20
| |||
Form 4
|
—
|
0
|
$40.83 | -$341,750.00 |
0
|
Scheduled
|
Nov 27
| ||
Form 4
|
—
|
0
|
$30.83 | -$241,750.00 |
0
|
Scheduled
|
Oct 29
| ||
Form 4
|
—
|
0
|
$34.67 | -$565,198.43 |
0
|
Aug 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 18
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
AVI BIOPHARMA INC (SRPT) Snapshot price: $128.92
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 31
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
MYMETICS CORP (MYMX) Snapshot price: $0.001
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||